UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selective Inhibition of Helicobacter pylori Carbonic Anhydrases by Carvacrol and Thymol Could Impair Biofilm Production and the Release of Outer Membrane Vesicles

International journal of molecular sciences, 2021-10, Vol.22 (21), p.11583

2021

Volltextzugriff (PDF)

Identification and characterization of the α-CA in the outer membrane vesicles produced by Helicobacter pylori

Journal of enzyme inhibition and medicinal chemistry, 2019-01, Vol.34 (1), p.189-195

2019

Volltextzugriff (PDF)

Antimicrobial efficacy of direct air gas soft jet plasma for the in vitro reduction of oral bacterial biofilms

Scientific reports, 2024-05, Vol.14 (1), p.10882-10882, Article 10882

2024

Volltextzugriff (PDF)

Antibiotic resistance and bacterial biofilm

Expert opinion on therapeutic patents, 2020-12, Vol.30 (12), p.897-900

2020

Volltextzugriff (PDF)

Prospective Real-Life Multicenter Study of Tildrakizumab 200 mg for Moderate-to-Severe Psoriasis: Who Is the Ideal Patient?

Dermatology practical & conceptual, 2024-10, Vol.14 (4), p.e2024284

2024

Volltextzugriff (PDF)

Biofilm and bacterial membrane vesicles: recent advances

Expert opinion on therapeutic patents, 2024-06, Vol.34 (6), p.475-491

2024

Volltextzugriff (PDF)

Etanercept in the treatment of generalized annular pustular psoriasis

Annals of Dermatology, 2012, 24(2), , pp.233-234

2012

Volltextzugriff (PDF)

Antimicrobial and Antibiofilm Activities of Carvacrol, Amoxicillin and Salicylhydroxamic Acid Alone and in Combination vs. IHelicobacter pylori:/I Towards a New Multi-Targeted Therapy

International journal of molecular sciences, 2023-02, Vol.24 (5)

2023

Volltextzugriff (PDF)

Cyclization of acyl thiosemicarbazides led to new Helicobacter pylori α‐carbonic anhydrase inhibitors

Archiv der Pharmazie (Weinheim), 2024-11, Vol.357 (11), p.e2400548-n/a

2024

Volltextzugriff (PDF)

Erlotinib-containing benzenesulfonamides as anti- Helicobacter pylori agents through carbonic anhydrase inhibition

Future medicinal chemistry, 2023-10, Vol.15 (20), p.1865-1883

2023

Volltextzugriff (PDF)

Solid lipid nanoparticles for efficient delivery of capsaicin-rich extract: Potential neuroprotective effects in Parkinson’s disease

Journal of drug delivery science and technology, 2024-01, Vol.91, p.105097, Article 105097

2024

Volltextzugriff (PDF)

Multiple lipid nanoparticles as antimicrobial drug delivery systems

Journal of drug delivery science and technology, 2022-01, Vol.67, p.102887, Article 102887

2022

Volltextzugriff (PDF)

Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies

Clinics in dermatology, 2010-05, Vol.28 (3), p.337-343

2010

Volltextzugriff (PDF)

Erratum to “Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies” [ Clin Dermatol 2010; 28:337-343]

Clinics in dermatology, 2014-05, Vol.32 (3), p.451-451

2014

Volltextzugriff (PDF)

Variants of G protein-coupled receptors: a reappraisal of their role in receptor regulation

Biochemical Society transactions, 2016-04, Vol.44 (2), p.589-594

2016

Volltextzugriff (PDF)

Effects of Fusobacterium nucleatum on migration and cytokines production of ags gastric adenocarcinoma cell line

Italian journal of anatomy and embryology, 2022-08, Vol.126 (2), p.59-63

2022

Volltextzugriff (PDF)

The Immune System Response to IPorphyromonas gingivalis/I in Neurological Diseases

Microorganisms (Basel), 2023-10, Vol.11 (10)

2023

Volltextzugriff (PDF)

Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study

Journal of the European Academy of Dermatology and Venereology, 2024-09

2024

Volltextzugriff (PDF)

Letters to the Editor : Etanercept in the Treatment of Generalized Annular Pustular Psoriasis

Annals of dermatology, 2012-05, Vol.24 (2), p.233

2012

Volltextzugriff (PDF)

A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis: Who is the Ideal Patient?

Dermatology practical & conceptual, 2024-10

2024

Volltextzugriff (PDF)

A multidisciplinary care unit approach for the management of psoriatic arthritis: an Italian experience

Italian Journal of Dermatology and Venereology, 2022-10, Vol.157 (5)

2022

Volltextzugriff (PDF)

Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study

Journal of clinical medicine, 2024-05, Vol.13 (9), p.2552

2024

Volltextzugriff (PDF)

Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies: Controversies in Dermatology: Part II

Clinics in dermatology, 2010, Vol.28 (3), p.337-343

2010

Volltextzugriff (PDF)

Contact pemphigus: a side-effect of imiquimod therapy

International journal of dermatology, 2008-07, Vol.47 (7), p.765-767

2008

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(64)
Berichte
(1)

Sprache

Englisch
(64)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Selective Inhibition of Helicobacter pylori Carbonic Anhydrases by Carvacrol and Thymol Could Impair Biofilm Production and the Release of Outer Membrane Vesicles

Identification and characterization of the α-CA in the outer membrane vesicles produced by Helicobacter pylori

Antimicrobial efficacy of direct air gas soft jet plasma for the in vitro reduction of oral bacterial biofilms

Antibiotic resistance and bacterial biofilm

Prospective Real-Life Multicenter Study of Tildrakizumab 200 mg for Moderate-to-Severe Psoriasis: Who Is the Ideal Patient?

Biofilm and bacterial membrane vesicles: recent advances

Etanercept in the treatment of generalized annular pustular psoriasis

Antimicrobial and Antibiofilm Activities of Carvacrol, Amoxicillin and Salicylhydroxamic Acid Alone and in Combination vs. IHelicobacter pylori:/I Towards a New Multi-Targeted Therapy

Cyclization of acyl thiosemicarbazides led to new Helicobacter pylori α‐carbonic anhydrase inhibitors

Inhibition of Pseudomonas aeruginosa Carbonic Anhydrases, Exploring Ciprofloxacin Functionalization Toward New Antibacterial Agents: An In-Depth Multidisciplinary Study

Erlotinib-containing benzenesulfonamides as anti- Helicobacter pylori agents through carbonic anhydrase inhibition

Solid lipid nanoparticles for efficient delivery of capsaicin-rich extract: Potential neuroprotective effects in Parkinson’s disease

Multiple lipid nanoparticles as antimicrobial drug delivery systems

Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies

Erratum to “Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies” [ Clin Dermatol 2010; 28:337-343]

Variants of G protein-coupled receptors: a reappraisal of their role in receptor regulation

Effects of Fusobacterium nucleatum on migration and cytokines production of ags gastric adenocarcinoma cell line

The Immune System Response to IPorphyromonas gingivalis/I in Neurological Diseases

Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study

Letters to the Editor : Etanercept in the Treatment of Generalized Annular Pustular Psoriasis

A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis: Who is the Ideal Patient?

A multidisciplinary care unit approach for the management of psoriatic arthritis: an Italian experience

Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study

Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies: Controversies in Dermatology: Part II

Contact pemphigus: a side-effect of imiquimod therapy

Aktive Filter

Suchergebnisse filtern